Interestingly, compared to those in other organs, FERMT2 and COPG1 in normal kidney tissue were only moderately expressed, and their gene effect ranges were quite different between the RNAi and CRISPR/Cas9 screening groups in ccRCC cell lines. This evidence concerns the gene COPG1 and nonpapillary renal cell carcinoma.